The Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) has partnered with the nonprofit Global Health Investment Corp. (GHIC) on a program meant to advance the
More
The Department of Defense (DoD), in coordination with the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS), has awarded a $12.38 million contract to
More
The Department of Health and Human Services has tasked an innovation center within Texas A&M University System to support the production of COVID-19 vaccines under a $265M order. The university system's Center for Innovation in Advanced
More
The U.S. Food and Drug Administration (FDA) has released test performance data from four more serological tests kits from its independent performance validation study effort with the National Institutes of Health's (NIH)
More
Peter Highnam, former research director at the National Geospatial-Intelligence Agency, has been named deputy director of the Defense Advanced Research Projects Agency. DARPA said Monday Highnam will support the agency’s research projects in areas
More
The U.S. Army has conducted clinical trials of an inactivated Zika virus vaccine on 75 human adults at the Walter Reed Army Institute of Research, DoD News reported Tuesday. Cheryl Pellerin writes WRAIR will
More
The Department of Health and Human Services has decided to move $81 million in funds from other research programs to efforts that seek to advance development work on vaccines against Zika virus,
More
The Department of Health and Human Services has offered financial and technical assistance to Brazil-based Butantan Institute in an effort to help the biomedical research center produce vaccines against Zika virus. HHS’ Biomedical Advanced Research and Development
More
The Walter Reed Army Institute of Research and partners at the Beth Israel Deaconess Medical Center have conducted preclinical research on a vaccine candidate to potentially prevent the Zika virus in humans, the
More
The Department of Health and Human Services will invest up to $90 million over five years in a partnership with Rempex Pharmaceuticals to further develop an experimental drug against biothreat pathogens and drug-resistant
More